Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnosis (Laboratory Tests, and Imaging Tests), Indication (Pain & Cramping, Diarrhea, Constipation, and Alternating Constipation & Diarrhea)

No. of Pages: 112    |    Report Code: TIPRE00022438    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in bowel's disease prevalence
  • 5.1.2 Growth in demand for personalized therapeutics
5.2 Market Opportunities
  • 5.2.1 Expansion in chronic disease management
  • 5.2.2 Growth in the need for innovative treatments for bowel's disease
5.3 Future Trends
  • 5.3.1 Increasing focus on precision medicine
  • 5.3.2 Growth in advanced therapeutics for inflammatory bowel diseases
5.4 Impact of Drivers and Restraints

6. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Regional Analysis

6.1 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Overview
6.2 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue 2018-2028 (US$ Million)
6.3 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast Analysis

7. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Diagnosis

7.1 Laboratory Tests
  • 7.1.1 Overview
  • 7.1.2 Laboratory Tests: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Imaging Tests
  • 7.2.1 Overview
  • 7.2.2 Imaging Tests: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Indication

8.1 Pain & Cramping
  • 8.1.1 Overview
  • 8.1.2 Pain & Cramping: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Diarrhea
  • 8.2.1 Overview
  • 8.2.2 Diarrhea: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Constipation
  • 8.3.1 Overview
  • 8.3.2 Constipation: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Alternating Constipation & Diarrhea
  • 8.4.1 Overview
  • 8.4.2 Alternating Constipation & Diarrhea : Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Asia-Pacific Analysis

9.1 Asia-Pacific
  • 9.1.1 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Key Country, 2021 and 2028 (%)
  • 9.1.1.1 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 China: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 China: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
    • 9.1.1.1.2 China: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication
  • 9.1.1.2 India: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 India: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
    • 9.1.1.2.2 India: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication
  • 9.1.1.3 Japan: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 Japan: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
    • 9.1.1.3.2 Japan: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication
  • 9.1.1.4 Australia: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.4.1 Australia: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
    • 9.1.1.4.2 Australia: Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication
  • 9.1.1.5 Rest of Asia-Pacific : Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
    • 9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Genova Diagnostics
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Commonwealth Diagnostics International
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Prometheus Laboratories
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Inova Diagnostics, Inc.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Biohit Oyj
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Aerodiagnostics, LLC
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market

  1. Genova Diagnostics
  2. Commonwealth Diagnostics International
  3. Prometheus Laboratories
  4. Inova Diagnostics, Inc.
  5. Biohit Oyj
  6. Aerodiagnostics, LLC
asia-pacific-irritable-bowel-syndrome-ibs-diagnostics-market